Hollander David
Insider CIK 1793796 · AERI Chief R&D Officer · KPRX Director · RVNC CMO & Global Therapeutics Lead · MANE Chief R&D Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MANE Veradermics, Inc | A Award deriv | 2026-09-01 | 2026-09-03 | 19,300 | — | $0 | 19,300 | SEC↗ |
| MANE Veradermics, Inc | A Award | 2026-09-01 | 2026-09-03 | 9,650 | — | $0 | 9,650 | SEC↗ |
| MANE Veradermics, Inc | A Award deriv | 2026-09-01 | 2026-09-03 | 19,300 | — | $0 | 19,300 | SEC↗ |
| MANE Veradermics, Inc | A Award | 2026-09-01 | 2026-09-03 | 9,650 | — | $0 | 9,650 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2026-06-10 | 2026-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2025-04-01 | 2025-04-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 95,212 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 9,733 | $3.65 | $35.5K | 95,212 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2024-11-18 | 2024-11-19 | 3,908 | $4.17 | $16.3K | 104,945 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2024-07-01 | 2024-07-03 | 1,778 | — | $0 | 1,778 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2023-09-29 | 2023-10-03 | 0 | — | $0 | 5,000 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2023-03-03 | 2023-03-07 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | F Tax w/h | 2022-02-04 | 2022-02-08 | 927 | $7.05 | $6.5K | 30,749 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2022-02-01 | 2022-02-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2022-02-01 | 2022-02-03 | 4,000 | — | $0 | 4,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | F Tax w/h | 2021-11-11 | 2021-11-15 | 2,162 | $12.06 | $26.1K | 31,676 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2021-02-04 | 2021-02-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2021-02-04 | 2021-02-08 | 11,000 | — | $0 | 33,838 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | F Tax w/h | 2020-11-11 | 2020-11-12 | 2,162 | $13.05 | $28.2K | 22,838 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2019-11-11 | 2019-11-13 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award | 2019-11-11 | 2019-11-13 | 25,000 | — | $0 | 25,000 | SEC↗ |